Search and Browse
Download
Enter Data
| Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nuclear receptor ROR-gamma (RORC) (Homo sapiens (Human)) | BDBM498079 ((5'S)-N-{[5- (Ethylsulfonyl)pyridin- 2-yl]methyl}-...) | PDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | 3.27 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Eli Lilly and Company US Patent | Assay Description Receptor competition binding assays are run in a buffer made up of DPBS (1 L) (Hyclone #SH30028.03), 2.2 g BSA Fraction v (Roche #9048-46-8), 100 mL ... | US Patent US11008336 (2021) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (RORC) (Homo sapiens (Human)) | BDBM498077 (N-[4- (Ethylsulfonyl)benzyl]- 5'-methyl-1-{1-[6- (...) | PDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | 4.42 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Eli Lilly and Company US Patent | Assay Description Receptor competition binding assays are run in a buffer made up of DPBS (1 L) (Hyclone #SH30028.03), 2.2 g BSA Fraction v (Roche #9048-46-8), 100 mL ... | US Patent US11008336 (2021) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (RORC) (Homo sapiens (Human)) | BDBM498074 ((5′S)—N-[4-(Ethylsulfonyl)benzyl]-5′-m...) | PDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | 5.88 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Eli Lilly and Company US Patent | Assay Description Receptor competition binding assays are run in a buffer made up of DPBS (1 L) (Hyclone #SH30028.03), 2.2 g BSA Fraction v (Roche #9048-46-8), 100 mL ... | US Patent US11008336 (2021) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (RORC) (Homo sapiens (Human)) | BDBM498076 ((5'S)-N-{[5- (Ethylsulfonyl)pyridin- 2-yl]methyl}-...) | PDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | 6.04 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Eli Lilly and Company US Patent | Assay Description Receptor competition binding assays are run in a buffer made up of DPBS (1 L) (Hyclone #SH30028.03), 2.2 g BSA Fraction v (Roche #9048-46-8), 100 mL ... | US Patent US11008336 (2021) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (RORC) (Homo sapiens (Human)) | BDBM498078 (N-{[5- (Ethylsulfonyl)pyridin- 2-yl]methyl}-5'- me...) | PDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | 10.8 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Eli Lilly and Company US Patent | Assay Description Receptor competition binding assays are run in a buffer made up of DPBS (1 L) (Hyclone #SH30028.03), 2.2 g BSA Fraction v (Roche #9048-46-8), 100 mL ... | US Patent US11008336 (2021) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (RORC) (Homo sapiens (Human)) | BDBM498080 (1-[(1S)-1-(4- Cyanophenyl)ethyl]- N-[4- (ethylsulf...) | PDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | 15.8 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Eli Lilly and Company US Patent | Assay Description Receptor competition binding assays are run in a buffer made up of DPBS (1 L) (Hyclone #SH30028.03), 2.2 g BSA Fraction v (Roche #9048-46-8), 100 mL ... | US Patent US11008336 (2021) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-beta (Homo sapiens (Human)) | BDBM498081 ((5'S)-N-[4- (Ethylsulfonyl)benzyl]- 5'-methyl-1-{1...) | PDB MMDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | 151 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Eli Lilly and Company US Patent | Assay Description Receptor competition binding assays are run in a buffer made up of DPBS (1 L) (Hyclone #SH30028.03), 2.2 g BSA Fraction v (Roche #9048-46-8), 100 mL ... | US Patent US11008336 (2021) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-alpha (Homo sapiens (Human)) | BDBM498081 ((5'S)-N-[4- (Ethylsulfonyl)benzyl]- 5'-methyl-1-{1...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | 698 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Eli Lilly and Company US Patent | Assay Description Receptor competition binding assays are run in a buffer made up of DPBS (1 L) (Hyclone #SH30028.03), 2.2 g BSA Fraction v (Roche #9048-46-8), 100 mL ... | US Patent US11008336 (2021) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-alpha (Homo sapiens (Human)) | BDBM498076 ((5'S)-N-{[5- (Ethylsulfonyl)pyridin- 2-yl]methyl}-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | 1.05E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Eli Lilly and Company US Patent | Assay Description Receptor competition binding assays are run in a buffer made up of DPBS (1 L) (Hyclone #SH30028.03), 2.2 g BSA Fraction v (Roche #9048-46-8), 100 mL ... | US Patent US11008336 (2021) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-beta (Homo sapiens (Human)) | BDBM498076 ((5'S)-N-{[5- (Ethylsulfonyl)pyridin- 2-yl]methyl}-...) | PDB MMDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | 1.14E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Eli Lilly and Company US Patent | Assay Description Receptor competition binding assays are run in a buffer made up of DPBS (1 L) (Hyclone #SH30028.03), 2.2 g BSA Fraction v (Roche #9048-46-8), 100 mL ... | US Patent US11008336 (2021) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-alpha (Homo sapiens (Human)) | BDBM498074 ((5′S)—N-[4-(Ethylsulfonyl)benzyl]-5′-m...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | 3.11E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Eli Lilly and Company US Patent | Assay Description Receptor competition binding assays are run in a buffer made up of DPBS (1 L) (Hyclone #SH30028.03), 2.2 g BSA Fraction v (Roche #9048-46-8), 100 mL ... | US Patent US11008336 (2021) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-alpha (Homo sapiens (Human)) | BDBM498080 (1-[(1S)-1-(4- Cyanophenyl)ethyl]- N-[4- (ethylsulf...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | 3.27E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Eli Lilly and Company US Patent | Assay Description Receptor competition binding assays are run in a buffer made up of DPBS (1 L) (Hyclone #SH30028.03), 2.2 g BSA Fraction v (Roche #9048-46-8), 100 mL ... | US Patent US11008336 (2021) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-beta (Homo sapiens (Human)) | BDBM498082 ((5'S)-N-{[5- (Ethylsulfonyl)pyridin- 2-yl]methyl}-...) | PDB MMDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | 4.47E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Eli Lilly and Company US Patent | Assay Description Receptor competition binding assays are run in a buffer made up of DPBS (1 L) (Hyclone #SH30028.03), 2.2 g BSA Fraction v (Roche #9048-46-8), 100 mL ... | US Patent US11008336 (2021) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-beta (Homo sapiens (Human)) | BDBM498078 (N-{[5- (Ethylsulfonyl)pyridin- 2-yl]methyl}-5'- me...) | PDB MMDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | 4.84E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Eli Lilly and Company US Patent | Assay Description Receptor competition binding assays are run in a buffer made up of DPBS (1 L) (Hyclone #SH30028.03), 2.2 g BSA Fraction v (Roche #9048-46-8), 100 mL ... | US Patent US11008336 (2021) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-alpha (Homo sapiens (Human)) | BDBM498082 ((5'S)-N-{[5- (Ethylsulfonyl)pyridin- 2-yl]methyl}-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | 9.53E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Eli Lilly and Company US Patent | Assay Description Receptor competition binding assays are run in a buffer made up of DPBS (1 L) (Hyclone #SH30028.03), 2.2 g BSA Fraction v (Roche #9048-46-8), 100 mL ... | US Patent US11008336 (2021) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-beta (Homo sapiens (Human)) | BDBM498079 ((5'S)-N-{[5- (Ethylsulfonyl)pyridin- 2-yl]methyl}-...) | PDB MMDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | >1.25E+4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Eli Lilly and Company US Patent | Assay Description Receptor competition binding assays are run in a buffer made up of DPBS (1 L) (Hyclone #SH30028.03), 2.2 g BSA Fraction v (Roche #9048-46-8), 100 mL ... | US Patent US11008336 (2021) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-beta (Homo sapiens (Human)) | BDBM498077 (N-[4- (Ethylsulfonyl)benzyl]- 5'-methyl-1-{1-[6- (...) | PDB MMDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | >1.25E+4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Eli Lilly and Company US Patent | Assay Description Receptor competition binding assays are run in a buffer made up of DPBS (1 L) (Hyclone #SH30028.03), 2.2 g BSA Fraction v (Roche #9048-46-8), 100 mL ... | US Patent US11008336 (2021) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-beta (Homo sapiens (Human)) | BDBM498074 ((5′S)—N-[4-(Ethylsulfonyl)benzyl]-5′-m...) | PDB MMDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | >1.25E+4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Eli Lilly and Company US Patent | Assay Description Receptor competition binding assays are run in a buffer made up of DPBS (1 L) (Hyclone #SH30028.03), 2.2 g BSA Fraction v (Roche #9048-46-8), 100 mL ... | US Patent US11008336 (2021) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-alpha (Homo sapiens (Human)) | BDBM498079 ((5'S)-N-{[5- (Ethylsulfonyl)pyridin- 2-yl]methyl}-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | 1.93E+4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Eli Lilly and Company US Patent | Assay Description Receptor competition binding assays are run in a buffer made up of DPBS (1 L) (Hyclone #SH30028.03), 2.2 g BSA Fraction v (Roche #9048-46-8), 100 mL ... | US Patent US11008336 (2021) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-alpha (Homo sapiens (Human)) | BDBM498077 (N-[4- (Ethylsulfonyl)benzyl]- 5'-methyl-1-{1-[6- (...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | >2.04E+4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Eli Lilly and Company US Patent | Assay Description Receptor competition binding assays are run in a buffer made up of DPBS (1 L) (Hyclone #SH30028.03), 2.2 g BSA Fraction v (Roche #9048-46-8), 100 mL ... | US Patent US11008336 (2021) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-alpha (Homo sapiens (Human)) | BDBM498078 (N-{[5- (Ethylsulfonyl)pyridin- 2-yl]methyl}-5'- me...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | >2.04E+4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Eli Lilly and Company US Patent | Assay Description Receptor competition binding assays are run in a buffer made up of DPBS (1 L) (Hyclone #SH30028.03), 2.2 g BSA Fraction v (Roche #9048-46-8), 100 mL ... | US Patent US11008336 (2021) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-beta (Homo sapiens (Human)) | BDBM498080 (1-[(1S)-1-(4- Cyanophenyl)ethyl]- N-[4- (ethylsulf...) | PDB MMDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | >2.27E+4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Eli Lilly and Company US Patent | Assay Description Receptor competition binding assays are run in a buffer made up of DPBS (1 L) (Hyclone #SH30028.03), 2.2 g BSA Fraction v (Roche #9048-46-8), 100 mL ... | US Patent US11008336 (2021) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
